IRBESARTAN/HYDROCHLOROTHIAZIDE VIATRIS
As listed in the register: IRBESARTAN/HYDROCHLOROTHIAZIDE VIATRIS 300 mg/12,5 mg, comprimé
12,5 mg + 300 mg · comprimé
- Prescription only
- Active substance
- Hydrochlorothiazide + Irbésartan
- Made by
- VIATRIS SANTE
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | VIATRIS SANTE |
|---|---|
| Active substance | Hydrochlorothiazide + Irbésartan |
| Strength | 12,5 mg + 300 mg |
| Form | comprimé |
| Route | orale |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure décentralisée |
| Name in the register | IRBESARTAN/HYDROCHLOROTHIAZIDE VIATRIS 300 mg/12,5 mg, comprimé |
| Packs | plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s) · plaquette(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s) |
| CIS | 63378458 |
| CIP13 | 3400930172346 |
| CIP13 | 3400930172353 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- comprimé2 products
- 12,5 mg + 300 mg
- 12,5 mg + 150 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.